A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 135
- 试验地点
- 1
- 主要终点
- percent of subjects without heavy drinking
研究概览
简要总结
Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •alcohol use disorder
排除标准
- •inability to provide informed consent
研究组 & 干预措施
waitlist control
Patients in this arm will not be provided treatment during the study period.
Ria Treatment Platfrom
The Ria Treatment Platform is a telehealth approach that includes medical assessment, prescription of clinically appropriate medications for alcohol use disorder, individual and group coaching, educational video modules, and monitoring of breath alcohol concentrations through a Bluetooth-enabled breathalyzer.
干预措施: Ria Treatment Platform (Combination Product)
结局指标
主要结局
percent of subjects without heavy drinking
时间窗: last four weeks
percent of subjects without heavy drinking per timeline follow-back
Percent of subjects without heavy drinking days
时间窗: Final 4 weeks of the 12-week trial period
Heavy drinking is defined as 5 or more standard drinks per day for men and 4 or more standard drinks per day for women, as assessed by the Timeline Followback.
次要结局
- Proportion of abstinent days(12-week trial period)
- Liver function (ALT, AST, GGT)(12 weeks)